abstract |
According to the present invention, two crystalline polymorphs of the epothilone analog represented by Formula (I) are named Form A and Form B and mixtures thereof are given. In addition, methods for making new polymorphs, therapeutic methods for their use, and pharmaceutical dosage forms containing said polymorphs are provided. |